Skip to content

MObile Support Adapted to Individual Contexts

MObile Support Adapted to Individual Contexts (MOSAIC Study)

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06828549
Acronym
MOSAIC
Enrollment
547
Registered
2025-02-14
Start date
2025-03-21
Completion date
2028-11-30
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

family support, social support, text message, mobile health, hemoglobin A1c

Brief summary

This behavioral clinical trial evaluates an adaptively tailored, mobile phone-delivered intervention (MOSAIC) designed to support adults managing their type 2 diabetes. Adaptive means the intervention can change over time. Tailored means the intervention may be different for different participants. The main questions the study will aim to answer are: 1. Does the diabetes education and support delivered via the MOSAIC adaptive mobile phone-delivered intervention improve outcomes more than diabetes education and support delivered via print materials alone? This aim compares the study arms on outcomes such as glycemic management (hemoglobin A1c), diabetes distress, and psychosocial well-being. This aim also compares the study arms on intervention targets (mediators) including diabetes self-efficacy and self-care behaviors. 2. For whom does the MOSAIC adaptive tailoring approach improve outcomes more than the print materials alone? This aim examines how well the tailoring rules used for the MOSAIC intervention worked for different participants on the outcomes examined in the first aim. Participants will enroll in a 16-month study with assessments every 4 months. Assessments include completion of an A1c test and a survey. For those assigned to MOSAIC, they will experience 12-months of mobile phone-delivered support with 3 opportunities for intervention tailoring.

Detailed description

MOSAIC intervention components include: * Monthly coaching sessions (\ 30 minutes each) - Persons with diabetes (PWD) will engage in goal setting and skill building relevant to their self-identified diet, exercise, and/or stress management goal * Daily one-way and interactive text messages to support the PWD in meeting their goal and supporting medication adherence * Weekly interactive text messages asking the PWD to reflect on goal progress followed by personalized feedback from their coach * The option to invite an adult support person (SP). SPs may be invited to participate in monthly phone coaching and/or receive text messages (3 one-way texts per week and one interactive text per week) pertaining to supporting the PWD, per the MOSAIC intervention adaptive tailoring rules PWD participants will be randomized in a parallel design to the MOSAIC adaptive mobile phone-delivered intervention or to print materials alone. The study is powered to detect a 0.5% reduction in hemoglobin A1c. Analyses will examine effects during the intervention (4 and 8 months) and post-intervention (12 months) and sustained effects (16 months). Participants will be analyzed as randomized regardless of withdrawal from the intervention (i.e., intention-to-treat principals) and missing data will be imputed.

Interventions

BEHAVIORALMOSAIC

All MOSAIC PWD participants receive monthly phone coaching following a semi-structured protocol plus daily automated text message support. MOSAIC uses the mobile phone-delivered structure and functionality developed for FAMS (NCT04347291). Tailoring rules novel to MOSAIC determine phone coaching protocol content, text message content, and the involvement of a SP. Semi-structured protocols used in prior studies (and in the case of NCT04334109 adapted for mobile phone-delivery) are employed. Per tailoring rules, enrolled SPs may be invited to participate in monthly coaching calls with the PWD and/or receive text messages about supporting the PWD. The study will not assess outcomes or effects among SPs.

BEHAVIORALPrint Materials

Quality print materials about diabetes management provided upon enrollment and in quarterly study newsletters

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Alabama at Birmingham
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

The labs analyzing A1c results (primary outcome, hemoglobin A1c) are masked to the study description or participants' assigned condition.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

PERSONS WITH DIABETES: * Speaks and reads in English * 18-75 years old * Diagnosed with type 2 diabetes * Receiving outpatient care from a partnering clinic * Community-dwelling (e.g., not in a nursing facility) * Prescribed at least one diabetes medication * Owns a mobile phone SUPPORT PERSONS: * Speaks and reads in English * 18 years or older * Owns a mobile phone

Exclusion criteria

PERSONS WITH DIABETES: * Unable to communicate by phone * Currently pregnant * Currently undergoing treatment for cancer (e.g., radiation, chemotherapy) * Diagnosed with end-stage renal disease * Receiving hospice services\* * Diagnosed with congestive heart failure * Diagnosed with dementia * Diagnosed with schizophrenia * Demonstrated an inability to receive and respond to a text * Does not take medication on his/her own/medication administered by someone else SUPPORT PERSONS: * Demonstrated inability to receive \& respond to a text * Unable to communicate by phone

Design outcomes

Primary

MeasureTime frameDescription
Change in Hemoglobin A1c During Intervention PeriodBaseline and 4, 8, and 12 months post-baselineHemoglobin A1c assessed by mail-in A1c kits and/or taken from electronic health record (venipuncture or point-of-care) where higher values indicate worse glycemic management
Change in Hemoglobin A1c Sustained Post-intervention EffectsBaseline and 16 months post-baselineHemoglobin A1c assessed by mail-in A1c kits and/or taken from electronic health record (venipuncture or point-of-care) where higher values indicate worse glycemic management

Secondary

MeasureTime frameDescription
Change in Diabetes Distress During Intervention PeriodBaseline and 4, 8, and 12 months post-baselineAssessed by the Problem Areas in Diabetes (PAID-5) with scores ranging 0-100 where higher scores indicate more emotional, psychological and social distress related to diabetes management (worse)
Change in Diabetes Distress Sustained Post-intervention EffectBaseline and 16 months post-baselineAssessed by the Problem Areas in Diabetes (PAID-5) with scores ranging 0-100 where higher scores indicate more emotional, psychological and social distress related to diabetes management (worse)
Change in Psychosocial Well-being During Intervention PeriodBaseline and 4, 8, and 12 months post-baselineAssessed by the World Health Organization - Five Well-Being Index (WHO-5) with scores ranging 0 to 100 where higher scores indicate more well-being (better)
Change in Psychosocial Well-being Sustained Post-intervention EffectBaseline 16 months post-baselineAssessed by the World Health Organization - Five Well-Being Index (WHO-5) with scores ranging 0 to 100 where higher scores indicate more well-being (better)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026